Latest News for: keros

Edit

Regulation FD Presentation (Form 8-K) (Keros Therapeutics Inc)

Public Technologies 09 Jan 2026
Keros Therapeutics Inc published this content on January 09, 2026, and is solely ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Keros Therapeutics Inc)

Public Technologies 09 Jan 2026
0.5 ... Keros Therapeutics, Inc ... C/O KEROS THERAPEUTICS, INC., 1050 WALTHAM STREET, SUITE 302 3 ... C/O KEROS THERAPEUTICS, INC ... Keros Therapeutics Inc published this content on January 09, 2026, and is solely responsible for the information contained herein.
Edit

Keros Therapeutics Announces Final Results of Tender Offer

Nasdaq Globe Newswire 20 Nov 2025
LEXINGTON, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq ... .
Edit

Amendment to Tender Offer Statement (Form SC TO-I/A) (Keros Therapeutics Inc)

Public Technologies 20 Nov 2025
Keros Therapeutics, Inc ... Keros Therapeutics, Inc ... Keros Therapeutics, Inc ... Keros Therapeutics, Inc ... KEROS THERAPEUTICS, INC ... Keros Therapeutics Inc published this content on November 20, 2025, and is ...
Edit

Keros Therapeutics Announces Preliminary Results of Tender Offer

Nasdaq Globe Newswire 19 Nov 2025
LEXINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq ... .
  • 1

Article Search

tools
×
×
×
×